iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Drop in Short Interest

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a significant decrease in short interest in January. As of January 30th, there was short interest totaling 3,799 shares, a decrease of 40.0% from the January 15th total of 6,335 shares. Approximately 1.2% of the company’s stock are sold short. Based on an average daily trading volume, of 11,722 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 11,722 shares, the short-interest ratio is currently 0.3 days. Approximately 1.2% of the company’s stock are sold short.

iShares Health Innovation Active ETF Stock Performance

Shares of NYSEARCA:BMED traded up $0.13 during trading on Friday, reaching $30.48. 1,533 shares of the stock traded hands, compared to its average volume of 7,568. The stock has a market cap of $9.75 million, a P/E ratio of 24.91 and a beta of 0.84. The stock has a 50-day moving average of $30.84 and a two-hundred day moving average of $28.61. iShares Health Innovation Active ETF has a 52-week low of $20.57 and a 52-week high of $32.19.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.